Clinical Relevance of Efficacy Endpoints in OTC Headache Trials
โ Scribed by Lutz Pageler; Hans-Christoph Diener; Volker Pfaffenrath; Hubertus Peil; Bernhard Aicher
- Book ID
- 109100397
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 270 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0017-8748
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Patients with newly diagnosed acute myeloid leukaemia (AML) are increasingly being enrolled in clinical trials sponsored by pharmaceutical companies or the National Cancer Institute. These trials routinely exclude patients who are less likely to respond (LLTR), e.g. those with Zubrod pe
For more than 30 years the European Organization for Research and Treatment for Cancer (EORTC) has conducted, co-ordinated, and stimulated research on the experimental and clinical bases of treatment of cancer and related problems. For more than a decade the EORTC has included quality of life as an
We consider multivariate tests for comparing two treatments with multiple endpoints. The test decision is drawn from the simultaneous consideration of the univariate tests for the single endpoints. A general class of these tests, called cut-o! tests, can be given, which, however, can lead to highly